CN1353816A - 不可逆性神经损伤易感个体的鉴定方法,包括定量检测胃蛋白酶原i(pgi)和维生素b12浓度的步骤 - Google Patents

不可逆性神经损伤易感个体的鉴定方法,包括定量检测胃蛋白酶原i(pgi)和维生素b12浓度的步骤 Download PDF

Info

Publication number
CN1353816A
CN1353816A CN00808519A CN00808519A CN1353816A CN 1353816 A CN1353816 A CN 1353816A CN 00808519 A CN00808519 A CN 00808519A CN 00808519 A CN00808519 A CN 00808519A CN 1353816 A CN1353816 A CN 1353816A
Authority
CN
China
Prior art keywords
concentration
vitamin
analyte
pgi
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00808519A
Other languages
English (en)
Chinese (zh)
Inventor
彭蒂·西波南
马蒂·哈科南
奥斯莫·斯沃瓦尼米
埃里克·福斯布洛姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohit Oy
Original Assignee
Biohit Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oy filed Critical Biohit Oy
Publication of CN1353816A publication Critical patent/CN1353816A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
CN00808519A 1999-04-30 2000-04-28 不可逆性神经损伤易感个体的鉴定方法,包括定量检测胃蛋白酶原i(pgi)和维生素b12浓度的步骤 Pending CN1353816A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI990991 1999-04-30
FI990991A FI990991A7 (fi) 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi

Publications (1)

Publication Number Publication Date
CN1353816A true CN1353816A (zh) 2002-06-12

Family

ID=8554566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00808519A Pending CN1353816A (zh) 1999-04-30 2000-04-28 不可逆性神经损伤易感个体的鉴定方法,包括定量检测胃蛋白酶原i(pgi)和维生素b12浓度的步骤

Country Status (12)

Country Link
EP (1) EP1173764B1 (https=)
JP (1) JP2002543430A (https=)
CN (1) CN1353816A (https=)
AT (1) ATE319088T1 (https=)
AU (1) AU4299700A (https=)
DE (1) DE60026285T2 (https=)
DK (1) DK1173764T3 (https=)
ES (1) ES2258453T3 (https=)
FI (1) FI990991A7 (https=)
PT (1) PT1173764E (https=)
RU (1) RU2224258C2 (https=)
WO (1) WO2000067029A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010019L (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
RU2413940C2 (ru) * 2009-02-02 2011-03-10 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия Способ определения витамина b12 в водных растворах

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi

Also Published As

Publication number Publication date
DE60026285D1 (de) 2006-04-27
ATE319088T1 (de) 2006-03-15
PT1173764E (pt) 2006-06-30
EP1173764A1 (en) 2002-01-23
ES2258453T3 (es) 2006-09-01
EP1173764B1 (en) 2006-03-01
AU4299700A (en) 2000-11-17
RU2224258C2 (ru) 2004-02-20
FI990991L (fi) 2000-10-31
DE60026285T2 (de) 2006-11-09
WO2000067029A1 (en) 2000-11-09
FI990991A0 (fi) 1999-04-30
FI990991A7 (fi) 2000-10-31
JP2002543430A (ja) 2002-12-17
DK1173764T3 (da) 2006-05-08

Similar Documents

Publication Publication Date Title
Spencer et al. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH
Spencer et al. Current status and performance goals for serum thyrotropin (TSH) assays
Geens et al. Daily intake of bisphenol A and triclosan and their association with anthropometric data, thyroid hormones and weight loss in overweight and obese individuals
Srivastava et al. Point of care-a novel approach to periodontal diagnosis-a review
WO2009059150A2 (en) Biomarkers for fatty liver disease and methods using the same
Kropf et al. Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases.
Owen et al. Performance characteristics of an HPLC assay for urinary albumin
Finocchiaro et al. Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure
US20040229300A1 (en) Zinc-based screening test and kit for early diagnosis of prostate cancer
Rosano et al. Analytical and biological variability of serum creatinine and creatinine clearance: implications for clinical interpretation.
CN1353816A (zh) 不可逆性神经损伤易感个体的鉴定方法,包括定量检测胃蛋白酶原i(pgi)和维生素b12浓度的步骤
Zhang et al. Analysis of current status of quantitative detection of biomarkers for liver fibrosis in Clinical labs in China
Roberts et al. The serum anion gap
Woo et al. Relationship between the levels of holotranscobalamin and vitamin B12
US7211441B2 (en) Lipoprotein assay
Trivedi et al. Serum type III procollagen peptide as a non-invasive marker of liver damage during infancy and childhood in extrahepatic biliary atresia, idiopathic hepatitis of infancy and α1 antitrypsin deficiency
Bandi et al. Immunochemical methods for measurement of transferrin in serum: effects of analytical errors and inappropriate reference intervals on diagnostic utility.
Leary et al. Measuring albumin and calcium in serum in a dual test with the Hitachi 704
EP1159612B1 (en) Integrated assay for organ function, drugs and/or metabolites
CN1371427A (zh) 一种用于鉴别有血管及癌症疾病患病风险的个体的方法
Mitchell et al. Effect of bias in hematofluorometer measurements of protoporphyrin in screening programs for lead poisoning.
Sekikawa et al. Is examination of fructosamine levels valuable as a diagnostic test for diabetes mellitus?
Mallick et al. Comparative analysis of ELISA, FEIA and CLIA techniques in diagnostic immunoassays for thyroid stimulating hormone: A cross-sectional study form Morang, Nepal
Fernández-Reyes et al. Comparison of three fluids for calibration of the new Periotron® 8010
Cembrowski et al. Computer-controlled instrument system for sequential chemical testing III. Application to liver assessment.

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication